GlassScriptPhysician profile
Nayeon Kim
NPI 1306452883
$1,181.74
in general payments reported to CMS, 2019-2025
19 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $343 · 2022: $56.48 · 2023: $141 · 2024: $245 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $275.83 | 2021-2025 | |
| Pfizer INC. | $181.27 | 2024-2025 | |
| Lilly USA, LLC | $88.35 | 2021-2025 | Mounjaro, Zepbound |
| Nestle Healthcare Nutrition INC. | $83.76 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $79.25 | 2021-2023 | Breztri, Farxiga |
| Glaxosmithkline, LLC. | $57.25 | 2025 | Trelegy Ellipta, Bexsero |
| Janssen Pharmaceuticals, INC | $56.02 | 2023-2024 | Spravato |
| Amgen INC. | $55.28 | 2021-2025 | Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.55 | 2024-2025 | Jardiance |
| Medtronic, INC. | $40.76 | 2024-2025 | Intellis Adaptivestim, Venaseal |
| Biohaven Pharmaceutical Holding Company LTD. | $39.61 | 2022 | |
| Exact Sciences Corporation | $38.44 | 2025 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $25.23 | 2025 | Voquezna |
| Bausch Health US, LLC | $23.43 | 2025 | Aplenzin, Wellbutrin |
| Novo Nordisk INC | $20.00 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $16.96 | 2021 | |
| Hologic Sales and Service, LLC | $16.87 | 2022 | |
| Mylan Specialty L.P. | $15.69 | 2024 | Yupelri |
| Organon LLC | $14.19 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nayeon Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.